Risk factors for the development of gastric mucosal lesions in rheumatoid arthritis patients receiving long-term nonsteroidal anti-inflammatory drug therapy and the efficacy of famotidine obtained from the FORCE study.

• 資料種別: 博士論文
• タイトル: Risk factors for the development of gastric mucosal lesions in rheumatoid arthritis patients receiving long-term nonsteroidal anti-inflammatory drug therapy and the efficacy of famotidine obtained from the FORCE study.
• 著者・編者: Kobata, Yasunori; Yajima, Hiroshi; Yamao, Junichi; Tanaka, Yasuhito; Fukui, Hiroshi; Takakura, Yoshinori
• 著者標目: Kobata, Yasunori; Yajima, Hiroshi; Yamao, Junichi; Tanaka, Yasuhito; Fukui, Hiroshi; Takakura, Yoshinori
• 出版事項: Japan Rheumatism Association / Springer
• 出版年月日等: 2009-12
• 出版年（W3CDTF）: 2009-12
• 並列タイトル等: 関節リウマチ(RA)患者のNSAIDs長期投与における胃粘膜障害発生因子ならびにファモチジンの治療効果に関する検討
• タイトル（掲載誌）: Modern rheumatology
• 巻号年月日等（掲載誌）: 19 6
• 掲載巻: 19
• 掲載号: 6
• 掲載ページ: 629-636
• ISSN（掲載誌）: ISSN : 1439-7595
• 授与機関名: 奈良県立医科大学
• 授与年月日: 2015-03-16
• 報告番号: 乙第1354号
• 学位: 博士（医学）
• 本文の言語コード: eng
• 件名標目: NSAID; Steroid; Rheumatoid arthritis; Famotidine; Mucosal lesion
• 対象利用者: 一般
• 一般注記: type:Thesis; The objective of this study was to investigate the prevalence of gastric mucosal injury induced by nonsteroidal anti-inflammatory drugs (NSAIDs) in patients with rheumatoid arthritis (RA). Upper gastrointestinal endoscopy was performed on 100 RA patients treated with NSAIDs. Patient factors potentially contributing to the development of NSAID-induced gastric mucosal injury were identified by logistic regression analysis; gastric mucosal injury and ulcers were used as objective variables. Gastric mucosal injury was detected in 62 of 100 patients, and eight of these patients had ulcers. Previous history of ulcers, lifestyle, NSAID dosage, and body mass index were associated with the development of gastric mucosal injury, and the use of diclofenac and steroid dose were associated with the development of ulcers. Disease-modifying antirheumatic drugs (DMARDs) did not appear to influence the risk of NSAID-induced gastric mucosal injury. RA patients treated for long periods with NSAIDs for RA symptoms should be controlled with DMARDs, without consideration of increased doses of steroids, in terms of risk for NSAID-induced gastric mucosal injury. Simultaneously, concomitant use of histamine-2 receptor antagonists (H2RA) such as famotidine should be considered.; 博士（医学）・乙第1354号・平成27年3月16日; © Japan College of Rheumatology 2009; © Springer International Publishing AG, Part of Springer Science+Business Media; identifier:Modern rheumatology Vol.19 No.6 p.629-636; identifier:14397595; identifier:http://ginmu.naramed-u.ac.jp/dspace/handle/10564/2972; identifier:Modern rheumatology, 19(6): 629-636
• オンライン閲覧公開範囲: インターネット公開
• 関連情報（DOI）: 10.1007/s10165-009-0202-0
• 連携機関・データベース: 国立情報学研究所 : 学術機関リポジトリデータベース（IRDB）（機関リポジトリ）; https://irdb.nii.ac.jp
• 提供元機関・データベース: 奈良県立医科大学 : 奈良県立医科大学機関リポジトリ GINMU

目次

http://ginmu.naramed-u.ac.jp/dspace/bitstream/10564/2972/1/01%e6%9c%ac%e6%96%87%e3%81%ae%e8%a6%81%e6%97%a8.pdf fulltext

http://ginmu.naramed-u.ac.jp/dspace/bitstream/10564/2972/2/02%e5%af%a9%e6%9f%bb%e8%a6%81%e6%97%a8.pdf fulltext

http://ginmu.naramed-u.ac.jp/dspace/bitstream/10564/2972/3/03%e6%9c%ac%e6%96%87.pdf fulltext